Every material Form 8-K 21Shares Sui Staking ETF has filed with the SEC since July 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Starting August 27, 2026, the Trust will value its shares and calculate net asset value using the FTSE Sui Index instead of the CME CF Sui-Dollar Reference Rate - New York Variant, after the sponsor's license with CF Benchmarks ends August 31, 2026. The filing also changes the timing of the sponsor fee, which will now be paid at least quarterly in arrears instead of weekly, and renames the Trust from 21Shares Sui ETF to 21Shares Sui Staking ETF; the company says the other revisions do not materially affect shareholders' rights.
FTSE Sui Index replaces the CME CF Sui-Dollar Reference Rate - New York Variant for NAV calculations beginning August 27, 2026
Benchmark Licensing Agreement with FTSE International Limited is dated August 20, 2026, with a one-year initial term that renews automatically
Sponsor Fee moves from weekly to at least quarterly payment in arrears, still payable in SUI, under Amendment No. 1 dated August 26, 2026
Trust renamed on August 25, 2026 via Certificate of Amendment; Second Amended and Restated Trust Agreement signed August 26, 2026
21Shares US LLC, the sponsor of the 21Shares Sui ETF, gave CF Benchmarks notice on June 30, 2026 that it is terminating the licensing agreement for the CME CF Sui Dollar Reference Rate, effective August 31, 2026. The sponsor plans to license FTSE index data on or about August 24, 2026, as part of a broader move to a new benchmark provider. Because the benchmark is used to value the trust's shares daily and to calculate net asset value, shareholders will be affected by this change of provider.
Sponsor gave termination notice to CF Benchmarks on June 30, 2026, effective August 31, 2026
Terminated agreement covers the CME CF Sui Dollar Reference Rate, New York Variant, used to value shares and calculate NAV
Sponsor intends to enter a licensing agreement with FTSE International Limited on or about August 24, 2026
FTSE license is expected to have a one-year initial term that renews automatically
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every 21Shares Sui Staking ETF filing is on SEC EDGAR ↗. 8-K briefs of other companies →